OpenHDI · Open Health Data Impact

Genome-directed treatment targets and mutational signature biomarkers: a retrospective, pan-solid tumour analysis.

Research paper from Europe PMC. Evidence status: source reported.

Published
2026-11-16
Source reference
MED:43039016
DOI
10.1016/s1470-2045(26)00406-7
Jurisdiction
Not assessed
Licence
Bibliographic metadata only; article rights retained

Black D, Davies HR, DeVerinne C, Cubric M, Chalivelaki Chan G, Czarnecki J, Rinaldi G, Zhao SJ, Degasperi A, Marciniak S, Rintoul RC, McCaughan F, Middleton G, Nik-Zainal S. · Lancet Oncol · im; journal article · Found via: Genomics England

Source: https://europepmc.org/article/MED/43039016. Captured 2026-11-18.

Limitations: Discovered through a Europe PMC keyword search for Genomics England. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.